Ultra-late recurrence (15 years or longer) of cutaneous melanoma

Cancer

Volumn 79, Issue 12, 1997, Pages 2361-2370

  Tsao, Hensin ^a   Cosimi, A Benedict ^a   Sober, Arthur J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Delayed; Melanoma; Recurrence; Ultra late

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS;

EID: 0030902368     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970615)79:12<2361::AID-CNCR10>3.0.CO;2-P     Document Type: Article

References (29)

1. Slingluff CL Jr., Dodge RK, Stanley SE, Seigler HF. The annual risk of melanoma progression. Implications for the concept of cure. Cancer 1992;70:1917-27.
2. Briele HA, Beattie CW, Ronan SG, Chaudhuri PK, DasGupta TK. Late recurrence of cutaneous melanoma. Arch Surg 1983;118:800-3.
3. Shaw HM, Beattie CW, McCarthy WH, Milton GW. Late relapse from cutaneous stage I malignant melanoma. Arch Surg 1985;120:1155-9.
4. Callaway MP, Briggs JC. The incidence of late recurrence (greater than 10 years): an analysis of 536 consecutive cases of cutaneous melanoma. Br J Plast Surg 1989;42:46-9.
5. Crowley NJ, Seigler HF. Late recurrence of malignant melanoma: analysis of 168 patients. Ann Surg 1990;212:173-7.
6. Koh HK, Sober AJ, Fitzpatrick TB. Late recurrence of cuta neous malignant melanoma. JAMA 1984;251:1859-62.
7. Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-81.
8. Raderman D, Giler S, Rothem A, Ben-Bassat M. Late metastases (beyond ten years) of cutaneous malignant melanoma. J Am Acad Dermatol 1986;15:374-8.
9. Levy E, Silverman K, Vossaert KA, Kopf AW, Bart RS, Golomb FM, et al. Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors. Melanoma Res 1991;1:63-7.
10. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, editors. Cutaneous melanoma. Philadelphia: J.B. Lippincott Co, 1992:165-87.
11. Balch CM, Soong SJ, Milton GW, Shaw HM, McCovern VJ, Murad TM, et al. A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg 1982;196:677-84.
12. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage 1 malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
13. Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627-30.
14. Markowitz JS, Cosimi LA, Carey RW, Kang S, Padyk C, Sober AJ, et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991;126:703-8.
15. Pearlman NW, Takach TJ, Robinson WA, Ferguson J, Cohen AL. A case-control study of late recurrence of malignant melanoma. Am J Surg 1992;164:458-61.
16. Clark WH Jr., Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-904.
17. Day CL, Mihm MC Jr., Sober AJ, Harris MN, Kopf AW, Fitzpatrick TB, et al. Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. J Am Acad Dermatol 1983;8:864-8.
18. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal transplant patients. Lancet 1986;i:1196.
19. Gartner MFRM, Fearns C, Lynette Wilson E, Campbell JAH, Dowdle EB. Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression. Br J Cancer 1992;65:487-90.
20. Moseley HS, Giuliano AE, Storm FK, Clark WH Jr., Robinson DS, Morton DL. Multiple primary melanoma. Cancer 1979;43:939-44.
21. Tahery DP, Moy RL. Lack of predictive factors in late recurrence of stage I melanoma. Int J Dermatol 1992;31:629-31.
22. McEwan L, Smith JG, Matthews JP. Late recurrence of localized cutaneous melanoma: its influence on follow-up policy. Plast Reconstr Surg 1990;86:527-34.
23. Briggs JC, Ibrahim NBN. Late recurrence of cutaneous melanoma. J Am Acad Dermatol 1988;18:147-8.
24. Gutman M, Klausner JM, Inbar M, Rozin RR. Late recurrence of stage I malignant melanoma. J Surg Oncol 1989;42:96-8.
25. Steiner A, Wolf C, Pehamberger H, Wolff K. Late metastases of cutaneous malignant melanoma. Br J Dermatol 1986;114:737-40.
26. Ariel IM. Theories regarding the cause of malignant melanoma. Surg Gynecol Obstet 1980;150:907-17.
27. Jackson R. Observations on the natural course of skin cancer. Can Med Assoc J 1965;92:564-70.
28. Hendrix RC. Unusual survival patterns of patients with metastatic melanoma. Cancer 1969;24:574-6.
29. Avril MF, Nguyen T, Duvillard P, Bognel C, Margulis A. Recurrences tardives de melanome. Au-dela de 10 ans. Ann Dermatol Venereol 1994;121:454-8.